Startseite
Impressum
Datenschutz
 
Volume 37, 7 April 2006 4/2006
 
  SPOT ON
 

Clinical trials with biologicals in healthy subjects: study protocols must not be confidential

 
  NEW INDICATION
 

TNF-alpha-antibody Infliximab (REMICADE) for psoriasis

 
  THERAPY FROM A CRITICAL VIEWPOINT
 

Clopidogrel (ISCOVER; PLAVIX) plus aspirin in long-term secondary prevention?
Fondaparinux (ARIXTRA) in acute coronary syndrome or myocardial infarction?

 
  IN BRIEF
 

Myocardial infarction: enoxaparin (CLEXANE) versus unfractionated heparin (e.g. LIQUEMIN)
Reference pricing for proton pump inhibitor PANTOZOL: fairy-tales from Altana
Advertisement for DELIX: dupery

 
  CURRENT ADR NETWORK REPORT

Is pelargonium-extract (UMCKALOABO) hepatotoxic?

 
  SIDE EFFECTS
 

Topical pimecrolimus (e.g. ELIDEL) and tacrolimus (PROTOPIC): suspicion of carcinogenicity unchanged

 
© arznei-telegramm 4/2006